The unnamed 60-year-old sought help from medics in Paris, France after suddenly developing health just four weeks after being jabbed with a Covid vaccine.

The company’s strategy focuses on steadily increasing its dividend, reinvesting in the business with strong financial returns, and carrying out value-driven share buybacks.

U.S. pharma companies should pay rather more of their corporate income tax in the U.S.—and start producing more of their best drugs in the U.S. as well.

Lower-than-expected pregnancy loss following flu vaccine, however. HHS wants 18-month hold on FOIA litigation related to ...

The impact of AI in the workplace is already profound, but that impact is expected to grow exponentially in the coming years, ...

Fueled by a sustained boom in sales of its diabetes and obesity products, Eli Lilly will become the world’s top-seller of prescription drugs by 2030 and will hold the top rung by a wide margin. | ...

Pfizer’s Q1 earnings call delivered a rollercoaster of cautious optimism. CEO Albert Bourla credited solid execution in ...

In this interview with TRUST-I and TRUST-II trial investigator, Jorge J. Nieva, MD, USC Keck School of Medicine, he walks ...

In the wake of Robert F. Kennedy Jr.’s abrupt revamp of the CDC’s Advisory Committee on Immunization Practices, details from ...

As if Wall Street wasn't troubled enough, the market has been in turmoil across early June thanks to the resurgence of geopolitical unrest in the Middle East. Throw in continued uncertainty ...

Pfizer’s 7%+ yield is tempting, but rising political, regulatory, and business risks threaten its stability and growth ...